Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study

| May 15, 2009 | 0 Comments

by David V. Sheehan, MD, MBA; Harry A. Croft, MD; E. Roderich Gossen, PhD; Randy J. Levitt, PhD; Claire Brullé, MD; Sylvie Bouchard, MD, PhD; Anna Rozova, MSc, MD

Dr. Sheehan is Distinguished University Health Professor, Professor of Psychiatry, Director, Depression and Anxiety Disorders Research Institute, University of South Florida College of Medicine, Tampa, Florida; Dr. Croft is Medical Director, San Antonio Psychiatric Research Center, San Antonio, Texas; Drs. Gossen, Levitt, Brullé, and Rozova are from Labopharm Inc., Laval, Québec, Canada; and Dr. Bouchard is from Lakeshore General Hospital, Montréal, Québec, Canada.

The content you are trying to view is restricted to registered members only.
Membership to Innovations in Clinical Neuroscience is free, so please consider becoming a member today.
Thank you
ICNS Online Editor
Please Login or Register for access.

Tags: , , , , , ,

Category: Mood Disorders, Original Research, Past Articles, Psychiatry

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.